Differential expression of selected gene products in uterine leiomyomata and adenomyosis

article OA: bronze CC0 ⤵ 8 in-corpus citations
AI-generated summary by claude@2026-07, 2026-07-07

Immunohistochemistry revealed significant differences in the expression of ERα, PR-A, RXRα, IGF-II, IGFI-Rβ, PDGF, EGFR, and BCL-2 between adenomyosis and uterine leiomyomata tissues.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Gene products estrogen receptor alpha, progesterone receptor-A, retinoid X receptor alpha, insulin-like growth factor-II, insulin-like growth factor I receptor beta, platelet-derived growth factor, epithelial growth factor receptor, and BCL-2 were examined by immunohistochemistry with the aid of a tissue microarray from 46 hysterectomies with adenomyosis and leiomyomata. With appropriate internal controls, there were significant differences in gene expression between adenomyosis and leiomyomata.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Endometriosis Endometriosis Gene Expression Profiling Leiomyomatosis Leiomyomatosis Adult Endometriosis Female Genetic Markers Genetic Markers Humans Immunohistochemistry Leiomyomatosis Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Cited by (8)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:06.633332+00:00
License: CC0 · commercial use OK